These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17939254)

  • 1. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
    Sumrall A; Dreiling B
    J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
    Pascual AM; Téllez N; Boscá I; Mallada J; Belenguer A; Abellán I; Sempere AP; Fernández P; Magraner MJ; Coret F; Sanz MA; Montalbán X; Casanova B
    Mult Scler; 2009 Nov; 15(11):1303-10. PubMed ID: 19825889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone-related acute leukemia in two MS patients.
    Pielen A; Goffette S; Van Pesch V; Gille M; Sindic CJ
    Acta Neurol Belg; 2008 Sep; 108(3):99-102. PubMed ID: 19115673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis.
    Ko MW; Tamhankar MA; Volpe NJ; Porter D; McGrath C; Galetta SL
    J Neurol Sci; 2008 Oct; 273(1-2):144-7. PubMed ID: 18687447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
    Ellis R; Boggild M
    Mult Scler; 2009 Apr; 15(4):505-8. PubMed ID: 19251838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
    Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
    Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
    Colovic N; Suvajdzic N; Kraguljac Kurtovic N; Djordjevic V; Dencic Fekete M; Drulovic J; Vidovic A; Tomin D
    Biomed Pharmacother; 2012 Apr; 66(3):173-4. PubMed ID: 22440894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
    Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
    Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief review.
    Bowles DW; Flaig TW
    Cancer Invest; 2006; 24(5):517-20. PubMed ID: 16939961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
    Stroet A; Gold R; Chan A
    Neurology; 2012 Mar; 78(12):933; author reply 933-4. PubMed ID: 22431743
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
    Singhal BS; Geeta S; Hundalani SG; Menon S
    Neurol India; 2009; 57(4):418-23. PubMed ID: 19770542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxanthrone-induced acute myeloid leukaemia presenting with leukaemia cutis.
    Fleming JD; Walsh S; Salisbury J; Du-Vivier AW; Mufti G
    Eur J Dermatol; 2013; 23(3):419-20. PubMed ID: 23783563
    [No Abstract]   [Full Text] [Related]  

  • 13. The first case of mitoxantrone exposure in early pregnancy.
    De Santis M; Straface G; Cavaliere AF; Rosati P; Batocchi AP; Caruso A
    Neurotoxicology; 2007 May; 28(3):696-7. PubMed ID: 17227680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis].
    Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A;
    Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukaemia due to mitoxantrone.
    Prescrire Int; 2007 Aug; 16(90):153-6. PubMed ID: 17724842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.
    Martinez V; Mir O; Dômont J; Bouscary D; Goldwasser F
    Anticancer Drugs; 2007 Feb; 18(2):233-5. PubMed ID: 17159610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis.
    Mogenet I; Simiand-Erdociain E; Canonge JM; Pris J
    Ann Pharmacother; 2003 May; 37(5):747-8. PubMed ID: 12708958
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis.
    Zecca C; Petrini L; Limoni C; Staedler C; Gobbi C
    Eur Neurol; 2011; 65(1):40-5. PubMed ID: 21196739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
    Martinelli V; Cocco E; Capra R; Salemi G; Gallo P; Capobianco M; Pesci I; Ghezzi A; Pozzilli C; Lugaresi A; Bellantonio P; Amato MP; Grimaldi LM; Trojano M; Mancardi GL; Bergamaschi R; Gasperini C; Rodegher M; Straffi L; Ponzio M; Comi G;
    Neurology; 2011 Nov; 77(21):1887-95. PubMed ID: 22076543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current role of mitoxantrone in the treatment of multiple sclerosis.
    Cocco E; Marrosu MG
    Expert Rev Neurother; 2014 Jun; 14(6):607-16. PubMed ID: 24834466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.